Gilead Sciences Acquires Arresto Biosciences for $225,000,000

  • Feed Type
  • Date
    12/20/2010
  • Company Name
    Arresto Biosciences
  • Mailing Address
    3183 Porter Drive Palo Alto, CA 94304
  • Company Description
    Arresto BiosciencesTM is a biotech company that develops medicines to treat cancer and fibrotic diseases by targeting extracellular matrix proteins.
  • Website
    http://www.arresto.com
  • Transaction Type
    M&A
  • Transaction Amount
    $225,000,000
  • Transaction Round
  • Proceeds Purposes
  • M&A Terms
    Undisclosed

By posting a comment, you agree to our terms and conditions.